title: Antiarrhythmic agent cibenzoline attenuates latent obstruction in the left ventricular outflow tract of hypertrophic cardiomyopathy.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Nomura
authors.forename: Akiteru
authors.initials: A
authors.lastname: Kojima
authors.forename: Yota
authors.initials: Y
authors.lastname: Urakabe
authors.forename: Satoko
authors.initials: S
authors.lastname: Enomoto-Uemura
authors.forename: Susumu
authors.initials: S
authors.lastname: Nishikawa
authors.forename: Natsuya
authors.initials: N
authors.lastname: Keira
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Matsubara
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tatsumi
mesh_terms: D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D014694:Ventricular Outflow Obstruction / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline